$Vir Biotechnology (VIR.US)$$Sanofi (SNY.US)$Reuters· 4 mins ago Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more